THPO and Thrombocytopenia: There was a trend towards higher rates of grade 4 thrombocytopenia in the prior BCMA-TT cohort (46% versus 32%; p = 0.064), which translated to a higher rate of thrombopoietin mimetic use (27% versus 12%; p = 0.013) for the prior BCMA-TT group.